This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Comparative risk of rheumatoid arthritis between glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors in type 2 diabetes.
Journal of autoimmunity, 157, 103493
Citation
Yen, Fu-Shun; Wang, Shiow-Ing; Hwu, Chii-Min; Huang, Chien-Wei; Chang, Renin; Hsu, Chih-Cheng; Wei, James Cheng-Chung. (2025). Comparative risk of rheumatoid arthritis between glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors in type 2 diabetes.. Journal of autoimmunity, 157, 103493. https://doi.org/10.1016/j.jaut.2025.103493